Market Cap 45.22M
Revenue (ttm) 7.57M
Net Income (ttm) -76.58M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,011.62%
Debt to Equity Ratio -4.45
Volume 273,600
Avg Vol 450,500
Day's Range N/A - N/A
Shares Out 92.46M
Stochastic %K 34%
Beta 1.68
Analysts Sell
Price Target $3.33

Latest News on VRCA

Verrica Pharmaceuticals Appoints Noah L. Rosenberg, M.D.

Mar 26, 2025, 7:00 AM EDT - 4 weeks ago

Verrica Pharmaceuticals Appoints Noah L. Rosenberg, M.D.


Verrica Announces Pricing of $42.0 Million Public Offering

Nov 21, 2024, 7:30 AM EST - 5 months ago

Verrica Announces Pricing of $42.0 Million Public Offering


Verrica Announces Proposed Public Offering

Nov 20, 2024, 4:05 PM EST - 5 months ago

Verrica Announces Proposed Public Offering